Analytical Data
-
基因名
C19orf62
- Application
-
别名
BABA1_HUMAN; babam1; BRCA1 A complex subunit MERIT40; BRISC and BRCA1-A complex member 1; C19orf62; FLJ20571; HSPC142; hypothetical Protein LOC29086
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9NWV8
-
表达区间
1-329aa
-
氨基酸序列
MEVAEPSSPT EEEEEEEEHS AEPRPRTRSN PEGAEDRAVG AQASVGSRSE GEGEAASADD GSLNTSGAGP KSWQVPPPAP EVQIRTPRVN CPEKVIICLD LSEEMSLPKL ESFNGSKTNA LNVSQKMIEM FVRTKHKIDK SHEFALVVVN DDTAWLSGLT SDPRELCSCL YDLETASCST FNLEGLFSLI QQKTELPVTE NVQTIPPPYV VRTILVYSRP PCQPQFSLTE PMKKMFQCPY FFFDVVYIHN GTEEKEEEMS WKDMFAFMGS LDTKGTSYKY EVALAGPALE LHNCMAKLLA HPLQRPCQSH ASYSLLEEED EAIEVEATV
-
分子量
63 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C19orf62, known as Chromosome 19 Open Reading Frame 62, is a gene that has garnered attention due to its association with various cellular processes and potential implications in human diseases. Emerging research indicates that C19orf62 may play a critical role in regulating cellular stress responses, apoptosis, and cell proliferation. Its expression patterns have been linked to certain cancers and neurodegenerative disorders, suggesting that it could serve as a biomarker or therapeutic target. Given the lack of extensive characterization of the C19orf62 protein, researchers are increasingly focused on the production and study of its recombinant form to elucidate its biological functions and interactions. By utilizing recombinant DNA technology, scientists aim to generate C19orf62 protein for in vitro studies, enabling the exploration of its structural properties, functionality, and potential mechanisms of action. Understanding the role of C19orf62 in cellular processes may not only shed light on disease pathology but could also pave the way for novel therapeutic strategies. Therefore, the study of C19orf62 recombinant protein is an essential step towards unraveling its significance in health and disease, providing insights that could ultimately contribute to improved diagnostic and treatment approaches.
